TY - JOUR
T1 - Loss of protection by hypoxic preconditioning in aging Fischer 344 rat hearts related to myocardial glycogen content and Na+ imbalance
AU - Tani, Masato
AU - Honma, Yukako
AU - Takayama, Michiyo
AU - Hasegawa, Hiroshi
AU - Shinmura, Ken
AU - Ebihara, Yoshinori
AU - Tamaki, Kayoko
N1 - Funding Information:
This study was supported in part by grants from the Keio Health Consulting Center and the Ministry of Education, Culture and Science, Japan.
PY - 1999/3/1
Y1 - 1999/3/1
N2 - Objectives: The objective of this study was to determine whether hypoxic preconditioning (HP) could lessen the myocardial increase in [Na+](i), thus protecting the aging myocardium against ischemia. Background: A decrease in ischemic tolerance with aging is associated with an accelerated increase in [Na+](i) during ischemia. Ischemic preconditioning fails to protect the middle-aged and senescent myocardium against ischemia. Methods: Isolated hearts of young adult (12-week-old), middle-aged (50-week-old) and senescent (100-week-old) Fischer 344 rats were subjected to 25 min of ischemia with or without HP followed by 30 min of reperfusion. Left ventricular (LV) function, myocardial energy metabolites and [Na+](i) were measured. Results: In the older groups, the recovery of LV function and high-energy phosphates (HEPs) was lower with an increased release of creatine kinase (CK) during reperfusion than in the young group. The increased [Na+](i) at the end of ischemia was greater in the former groups than in the young group. HP decreased myocardial glycogen and lessened the increased [Na+](i) in the young group, resulting in an improved recovery of LV function and HEPs, as well as decreased CK release. However, the levels of glycogen before HP in the older groups were higher than in the young group and its levels after HP were similar to that before HP in the young group. HP did not affect the [Na+](i), exacerbated CK release and inhibited the recovery of LV function and HEPs in the older groups. Conclusions: HP failed to lessen the increased [Na+](i) or to protect the aging hearts, probably due to the preexistence of increased glycogen level.
AB - Objectives: The objective of this study was to determine whether hypoxic preconditioning (HP) could lessen the myocardial increase in [Na+](i), thus protecting the aging myocardium against ischemia. Background: A decrease in ischemic tolerance with aging is associated with an accelerated increase in [Na+](i) during ischemia. Ischemic preconditioning fails to protect the middle-aged and senescent myocardium against ischemia. Methods: Isolated hearts of young adult (12-week-old), middle-aged (50-week-old) and senescent (100-week-old) Fischer 344 rats were subjected to 25 min of ischemia with or without HP followed by 30 min of reperfusion. Left ventricular (LV) function, myocardial energy metabolites and [Na+](i) were measured. Results: In the older groups, the recovery of LV function and high-energy phosphates (HEPs) was lower with an increased release of creatine kinase (CK) during reperfusion than in the young group. The increased [Na+](i) at the end of ischemia was greater in the former groups than in the young group. HP decreased myocardial glycogen and lessened the increased [Na+](i) in the young group, resulting in an improved recovery of LV function and HEPs, as well as decreased CK release. However, the levels of glycogen before HP in the older groups were higher than in the young group and its levels after HP were similar to that before HP in the young group. HP did not affect the [Na+](i), exacerbated CK release and inhibited the recovery of LV function and HEPs in the older groups. Conclusions: HP failed to lessen the increased [Na+](i) or to protect the aging hearts, probably due to the preexistence of increased glycogen level.
KW - Aging
KW - Ischemia
KW - Na/H exchange
KW - Preconditioning
KW - Reperfusion
UR - http://www.scopus.com/inward/record.url?scp=0033040982&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033040982&partnerID=8YFLogxK
U2 - 10.1016/S0008-6363(98)00256-9
DO - 10.1016/S0008-6363(98)00256-9
M3 - Article
C2 - 10435031
AN - SCOPUS:0033040982
SN - 0008-6363
VL - 41
SP - 594
EP - 602
JO - Cardiovascular Research
JF - Cardiovascular Research
IS - 3
ER -